share_log
Benzinga ·  May 2 16:01
Ultragenyx Pharmaceutical Sees FY24 Revenue $500M-$530M Vs $513M Est
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment